Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc. Interpace Transitions to focused Molecular Diagnostics BusinessDisposition of Pharma Services Expected to Improve Operating Cash Flow by nearly $5 million Annually PARSIPPANY, NJ, Aug. 31, 2022 ...